U.S. market Closed. Opens in 11 hours 42 minutes

ALLR | Allarity Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/A120.00K
Cost of Revenue37.00K120.00K106.00K86.00KN/A
Gross Profit-37.00K-120.00K-106.00K-86.00K120.00K
Operating Expenses17.89M16.89M26.56M9.23M10.24M
Selling, General & Admin10.03M9.96M12.36M4.10M3.87M
Research & Development7.87M6.93M14.20M5.13M6.37M
Other Operating Expenses-20.42MN/A-474.00K-681.00KN/A
Operating Income-17.93M-34.46M-26.56M-9.23M-17.61M
Other Expenses / Income5.31M16.88M41.00K1.99M-1.37M
Before Tax Income-12.62M-17.58M-26.52M-7.23M-18.98M
Income Tax Expenses-717.00K-1.52M133.00K-2.16M-4.58M
Net Income-11.90M-16.06M-26.65M-5.07M-14.40M
Interest Expenses498.00K223.00K499.00K227.00K3.31M
Basic Shares Outstanding99.54K340.00227.00116.002.26K
Diluted Shares Outstanding99.54K340.00227.00116.002.26K
EBITDA-17.89M-16.80M-28.27M-9.86M-10.06M
EBITDA Margin0.00%0.00%0.00%0.00%-8,382.50%
EBIT-12.12M-17.36M-26.02M-7.01M-15.66M
EBIT Margin0.00%0.00%0.00%0.00%-13,054.17%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙